Pulmonary Hypertension in Dogs: Diagnosis and Therapy

被引:118
作者
Kellihan, Heidi B. [1 ]
Stepien, Rebecca L. [1 ]
机构
[1] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA
关键词
Sildenafil; Pulmonary disease; Syncope; Heart disease; Echocardiographic; Right heart catheterization; SILDENAFIL CITRATE THERAPY; PATENT DUCTUS-ARTERIOSUS; NATRIURETIC PEPTIDE CONCENTRATION; L-ARGININE; DOPPLER-ECHOCARDIOGRAPHY; RECEPTOR ANTAGONIST; ORAL SILDENAFIL; RIGHT VENTRICLE; TERM TREATMENT; OPEN-LABEL;
D O I
10.1016/j.cvsm.2010.03.011
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Pulmonary hypertension (PH) has been recognized as a clinical syndrome for many years in veterinary medicine, but routine accurate clinical diagnosis in dogs was greatly enhanced by widespread use of echocardiography and Doppler echocardiography Most cases of PH in veterinary medicine can be categorized as precapillary or postcapillary These subsets of patients often differ with regard to clinical presentation, response to therapy, and prognosis. Effective medical therapy is now available to treat this often-devastating clinical complication of common chronic diseases, making accurate diagnosis even more important to patient longevity and quality of life
引用
收藏
页码:623 / +
页数:20
相关论文
共 100 条
  • [1] N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension
    Andreassen, Arne K.
    Wergeland, Ragnhild
    Simonsen, Svein
    Geiran, Odd
    Guevara, Cecilia
    Ueland, Thor
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (04) : 525 - 529
  • [2] Evaluation of Pimobendan and N-Terminal Probrain Natriuretic Peptide in the Treatment of Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease in Dogs
    Atkinson, K. J.
    Fine, D. M.
    Thombs, L. A.
    Gorelick, J. J.
    Durham, H. E.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2009, 23 (06) : 1190 - 1196
  • [3] Bach JF, 2006, J VET INTERN MED, V20, P1132, DOI 10.1892/0891-6640(2006)20[1132:REOSCA]2.0.CO
  • [4] 2
  • [5] Theophylline - New perspectives for an old drug
    Barnes, PJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) : 813 - 818
  • [6] Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension - Open-label pilot study
    Barst, RJ
    Rich, S
    Widlitz, A
    Horn, EM
    McLaughlin, V
    McFarlin, J
    [J]. CHEST, 2002, 121 (06) : 1860 - 1868
  • [7] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    Barst, RJ
    Rubin, LJ
    Long, WA
    McGoon, MD
    Rich, S
    Badesch, DB
    Groves, BM
    Tapson, VF
    Bourge, RC
    Brundage, BH
    Koerner, SK
    Langleben, D
    Keller, CA
    Murali, S
    Uretsky, BF
    Clayton, LM
    Jobsis, MM
    Blackburn, SD
    Shortino, D
    Crow, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) : 296 - 301
  • [8] Baumwart RD, 2005, J VET INTERN MED, V19, P828, DOI 10.1892/0891-6640(2005)19[828:TIOMPA]2.0.CO
  • [9] 2
  • [10] Borgarelli Michele, 2004, J Vet Cardiol, V6, P27, DOI 10.1016/S1760-2734(06)70055-8